XML 38 R18.htm IDEA: XBRL DOCUMENT
v3.20.2

Shareholders' Equity | 12 Months Ended
--- | ---
Jun. 30, 2020
Equity [Abstract] |
Shareholders' Equity | 11. Shareholders' Equity At June 30, 2020 and 2019, authorized capital shares consisted of the following: 750 million Class A common shares, without par value; 5 million Class B common shares, without par value; and 500 thousand non-voting preferred shares, without par value. The Class A common shares and Class B common shares are collectively referred to below as “common shares”. Holders of common shares are entitled to share equally in any dividends declared by the Board of Directors and to participate equally in all distributions of assets upon liquidation. Generally, the holders of Class A common shares are entitled to one vote per share, and the holders of Class B common shares are entitled to one-fifth of one vote per share on proposals presented to shareholders for vote. Under certain circumstances, the holders of Class B common shares are entitled to vote as a separate class. Only Class A common shares were outstanding at June 30, 2020 and 2019. We repurchased $1.5 billion of our common shares, in the aggregate, through share repurchase programs during fiscal 2020, 2019 and 2018, as described below. We funded the repurchases with available cash and short term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes. During fiscal 2020, we repurchased 7.3 million common shares having an aggregate cost of $350 million. The average price paid per common share was $48.00. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on August 20, 2019 and was completed on December 4, 2019. During fiscal 2019, we repurchased 11.5 million common shares having an aggregate cost of $600 million. The average price paid per common share was $52.32. These repurchases were made under ASR program, which began on August 16, 2018 and was completed on October 25, 2018. During fiscal 2018, we repurchased 8.4 million common shares having an aggregate cost of $550 million. The average price paid per common share was $65.30. These repurchases include $300 million purchased under an ASR program, which began on February 14, 2018 and was completed on March 21, 2018. We repurchased 4.3 million shares under the ASR at an average price paid per share of $69.26. Accumulated Other Comprehensive Loss The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:
(in millions) | Foreign Currency Translation Adjustments and other |  | Unrealized Gain/(Loss) on Derivatives, net of tax |  | Accumulated Other Comprehensive Loss
Balance at June 30, 2018 | $ | (113 | ) |  | $ | 21 |  |  | $ | (92 | )
Other comprehensive income/(loss), net before reclassifications | 18 |  |  | — |  |  | 18 |
Amounts reclassified to earnings | — |  |  | (5 | ) |  | (5 | )
Total other comprehensive loss attributable to Cardinal Health, Inc., net of tax of $1 million | 18 |  |  | (5 | ) |  | 13 |
Balance at June 30, 2019 | (95 | ) |  | 16 |  |  | (79 | )
Other comprehensive loss, before reclassifications | 3 |  |  | (23 | ) |  | (20 | )
Amounts reclassified to earnings | — |  |  | (5 | ) |  | (5 | )
Total comprehensive income/(loss) attributable to Cardinal Health, Inc., net of tax of $4 million | 3 |  |  | (28 | ) |  | (25 | )
Balance at June 30, 2020 | $ | (92 | ) |  | $ | (12 | ) |  | $ | (104 | )

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration